Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:e301-e304
Published online before print April 9, 2009, doi: 10.1161/STROKEAHA.108.544551
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/5/e301    most recent
STROKEAHA.108.544551v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rudd, A. G.
Right arrow Articles by Williams, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudd, A. G.
Right arrow Articles by Williams, L. S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Other Stroke Treatment - Medical

(Stroke. 2009;40:e301.)
© 2009 American Heart Association, Inc.


Advances in Stroke 2008

Advances in Health Policy and Outcomes

Anthony G. Rudd, MD Linda S. Williams, MD

From the Royal College of Physicians (A.G.R.), London, UK; and the IU School of Medicine (L.S.W.), Indianapolis, Ind.

Correspondence to Anthony G. Rudd, FRCP (London), Programme Director for Stroke, Clinical Standards Department, Royal College of Physicians, 11 St Andrews Place, London NW1 4LE, UK. E-mail Anthony.rudd@kcl.ac.uk


Key Words: Health Policy • outcomes • Advances


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Many countries seem at last to be taking stroke seriously, recognizing that it is a treatable disease and that failing to treat it effectively results in unnecessary suffering and a huge waste of health service resources. However, too many patients in high, low, and middle income countries still receive inadequate care. Rates of thrombolysis in most countries are still below 1% and in only a few countries is there more than a 50% chance that a patient will be treated in a specialized stroke unit. Access to brain imaging is often too slow and rehabilitation, particularly after the acute phase, is frequently absent or lacking in the necessary quantity or quality.1,2 Recognition that there is a need for central planning, which should be done as a collaborative effort between clinicians, healthcare planners and politicians, is described in the essay by Larry Goldstein3 using the United States experience of policy development for stroke at a national and state level. He stresses the importance of clinicians being willingly engaged in the process to provide high quality information and expertise. George et al4 identify the importance of the components of a public health strategy designed to improve the quality of stroke care at a state level. The key issues are provision of leadership through policy development and assurance, sharing of information with providers, building capacity for conducting quality improvement activities and providing evidence-based guidelines, policies and plans as well as developing and enforcing laws and regulations to ensure the quality of stroke care. . . . [Full Text of this Article]